|
|
Article: Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash.
- Article from:
- Business Wire
- Article date:
- July 31, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Offer Represents Approximately 30% Premium to the Closing Price of ImClone's Stock on July 30, Approximately 40% Premium to the Average Share Price of ImClone Common Stock During the Most Recent One-Month Period and Premium in Excess of 40% for the Average Share Prices of ImClone Stock During the Most Recent Three-Month and 12-Month Periods
Combination Is Natural Development in Companies' Successful, Seven-Year-Long Relationship around ERBITUX[R]
NEW YORK -- Bristol-Myers Squibb Company (NYSE: BMY) today announced that it has proposed to enter into an agreement to acquire ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development ...